Claims for Patent: 7,268,156

Summary for Patent: 7,268,156

Title:	Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment
Abstract:	The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
Inventor(s):	Brook; Christopher S. (King of Prussia, PA), Chen; Wei (Woodbury, MN), Spoors; Paul G. (King of Prussia, PA)
Assignee:	SB Pharmco Puerto Rico Inc. (Hato Rey, PR)
Application Number:	10/518,654
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,268,156
Patent Claims:	1. A compound which is crystalline carvedilol dihydrogen phosphate hemihydrate. 2. The compound according to claim 1 having an x-ray diffraction pattern which comprises characteristic peaks in degrees two-theta as shown in FIG. 1. 3. The compound according to claim 2 having characteristic peaks from 0.degree. degrees 2-theta (2.theta.) to 35.degree. degrees 2-theta (2.theta.) at about 7.0.+-.0.2 (2.theta.), 11.4.+-.0.2 (2.theta.), 15.9.+-.0.2 (2.theta.), 18.8.+-.0.2 (2.theta.), 20.6.+-.0.2 (2.theta.), 22.8.+-.0.2 (2.theta.), and 25.4.+-.0.2 (2.theta.). 4. The compound according to claim 1 having an infrared spectrum which comprises characteristic absorption bands expressed in wave numbers as shown in FIG. 6. 5. The compound according to claim 1 having a Raman spectrum which comprises characteristic peaks as shown in FIG. 3. 6. A pharmaceutical composition comprising the compound according to claim 1 and a pharmaceutically acceptable carrier. 7. A method of treating hypertension, congestive heart failure or angina which comprises administering to a subject in need thereof an effective amount of the compound according to claim 1. 8. A method of treating hypertension, congestive heart failure or angina which comprises administering to a subject in need thereof an effective amount of the composition according to claim 6.